Moreover, a range of strategies (such as monoclonal neutralising antibodies and small-molecule inhibitors) to treat cancer and fibrosis have been developed against TGF-β1; highly expressed and produced by fibroblasts (139, 140). The gene discussed is TGFB1; the disease is cancer.